Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Debt (2016 - 2017)

Bone Biologics (BBLG) has disclosed Total Debt for 2 consecutive years, with $20.1 million as the latest value for Q3 2017.

  • On a quarterly basis, Total Debt rose 34.34% to $20.1 million in Q3 2017 year-over-year; TTM through Sep 2017 was $20.1 million, a 34.34% increase, with the full-year FY2016 number at $8.8 million, changed N/A from a year prior.
  • Total Debt was $20.1 million for Q3 2017 at Bone Biologics, up from $19.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $20.1 million in Q3 2017 to a low of $8.8 million in Q4 2016.